Cargando…
Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087576/ https://www.ncbi.nlm.nih.gov/pubmed/35765942 http://dx.doi.org/10.1111/ceo.14131 |
| _version_ | 1785022380117065728 |
|---|---|
| author | Mitchell, Paul Juneja, Prabhjot Wang, Chao Schnabel, Rebecca |
| author_facet | Mitchell, Paul Juneja, Prabhjot Wang, Chao Schnabel, Rebecca |
| author_sort | Mitchell, Paul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10087576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100875762023-04-12 Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion Mitchell, Paul Juneja, Prabhjot Wang, Chao Schnabel, Rebecca Clin Exp Ophthalmol Letters to the Editor John Wiley & Sons Australia, Ltd 2022-08-05 2022-12 /pmc/articles/PMC10087576/ /pubmed/35765942 http://dx.doi.org/10.1111/ceo.14131 Text en © 2022 The Authors. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Mitchell, Paul Juneja, Prabhjot Wang, Chao Schnabel, Rebecca Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| title | Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| title_full | Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| title_fullStr | Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| title_full_unstemmed | Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| title_short | Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| title_sort | australian pharmaceutical benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087576/ https://www.ncbi.nlm.nih.gov/pubmed/35765942 http://dx.doi.org/10.1111/ceo.14131 |
| work_keys_str_mv | AT mitchellpaul australianpharmaceuticalbenefitsschemedataonutilisationofintravitrealtherapyinretinalveinocclusion AT junejaprabhjot australianpharmaceuticalbenefitsschemedataonutilisationofintravitrealtherapyinretinalveinocclusion AT wangchao australianpharmaceuticalbenefitsschemedataonutilisationofintravitrealtherapyinretinalveinocclusion AT schnabelrebecca australianpharmaceuticalbenefitsschemedataonutilisationofintravitrealtherapyinretinalveinocclusion |